Sort
261,768 grants matching “gene therapy”
GENERAL CLINICAL RESEARCH CENTER
$2,458,920Yale University · M01 · FY2001 · RR
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab
$2,457,204Joren C Madsen · Massachusetts General Hospital · U01 · FY2020 · AI
SPORE in Lung Cancer
$2,457,135Paul A Bunn · University Of Colorado Denver · P50 · FY2009 · CA
Hematopoiesis in cardiovascular disease
$2,456,980Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2019 · HL
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,456,823Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
AIDS associated Toxoplasma encephalitis
$2,456,732Louis M. Weiss · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Synthetically Reengineered T cells as the Next Generation of Smart Cancer Therapy
$2,455,500Wilson Wong · Boston University (Charles River Campus) · DP2 · FY2013 · CA
B Lymphocyte-Mediated Autoimmunity in Pain After Trauma
$2,454,998David J Clark · Palo Alto Veterans Instit For Research · R01 · FY2020 · NS
Alcohol Pharmacokinetics and Pharmacodynamics in Humans
$2,454,429Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Development of Novel Vaccine Strategies
$2,453,605Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,453,222Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2024 · CA
A Protein Replacement Drug for Friedreichs Ataxia
$2,453,144Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
BMP Inhibitors to Treat Fibrodysplasia Ossificans Progressiva
$2,453,144Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Development of Malaria Transmission-Blocking Drugs
$2,453,144Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Repurposing an EU Therapeutic for Hemoglobinopathies
$2,453,144Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Convergent Epigenetic Control of Neuroendocrine Cancers
$2,452,400James A Decaprio · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Development of Novel Mycolytic Therapies for Lung Disease
$2,452,224David B Peden · Univ Of North Carolina Chapel Hill · P01 · FY2017 · HL
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
$2,450,827Adam Joel Bass · Dana-Farber Cancer Inst · P50 · FY2019 · CA
Defining the role of altered cytokine signaling pathways on autoimmunity
$2,450,784Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · U01 · FY2012 · AI
Regulation of gene expression in the retina
$2,450,485Anand Swaroop · National Eye Institute · ZIA · FY2010 · EY
Transformative research on the normal and Alzheimer's disease brain through studies of neuronal gene recombination
$2,449,857Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R56 · FY2019 · AG
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$2,449,375Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
SPORE IN BREAST CANCER
$2,449,341Baylor College Of Medicine · P50 · FY2001 · CA
Molecular Genetics Support to Identify Gene/Environment Interactions in Disease
$2,448,611Kevin Gerrish · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
Hematopoiesis in cardiovascular disease
$2,448,526Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2020 · HL